Recent Articles from Business Wire

RxERP, the serialized enterprise resource planning (ERP) platform purpose-built for the pharmaceutical supply chain, today announced that Mary Vrana has joined the company as EDI Program Manager. Vrana brings more than seven years of electronic data interchange (EDI) experience across nearly every corner of the pharmaceutical supply chain. At RxERP, she will lead the company's efforts to help manufacturers, wholesalers, distributors, micro-distributors, and 3PLs connect with their trading partners faster.

Otovo ASA (Euronext Oslo Børs: OTOVO; "Otovo"), an AI-enabled platform for behind-the-meter energy services for homes and businesses, today announced it has completed a private placement financing of $3 million in gross proceeds, bringing the total capital raised by Otovo to approximately $40 million in a little over 12 months. The completed equity raise and asset sale described below would provide over $5 million in combined proceeds, subject to the completion of the asset sale.

Perfect Corp. (NYSE: PERF) (“Perfect” or the “Company”), a leading artificial intelligence (“AI”) company offering AI and augmented reality (“AR”) powered solutions to beauty, fashion, photo and video creative industries, today announced the completion of the merger (the “Merger”), pursuant to the previously announced Agreement and Plan of Merger (the “Merger Agreement”), dated as of July 10, 2026, between the Company and ProjectNY, an exempted company with limited liability incorporated under the laws of the Cayman Islands controlled by Ms. Alice H. Chang (“Merger Sub”), and the plan of merger filed with the Registrar of Companies of the Cayman Islands (the “Plan of Merger”). In the Merger, Merger Sub merged with and into the Company, with the Company surviving the Merger as the surviving company. As a result of the Merger, the Company’s Class A ordinary shares ceased to be publicly traded.

Sierra Bancorp (Nasdaq: BSRR), parent of Bank of the Sierra, announced that its Board of Directors has approved a new share repurchase program authorizing the Company to repurchase up to one million (1,000,000) shares of its outstanding common stock, from time to time, commencing after the current share repurchase program expires on October 31, 2026, and continuing until October 31, 2027. This new share repurchase program replaces and supersedes the current share repurchase program dated October 23, 2025, for 1,000,000 shares. 381,532 shares remain available for repurchase under the current share repurchase program expiring on October 31, 2026. Shares may be repurchased in open-market transactions or privately negotiated transactions executed in compliance with applicable federal and state securities laws. The timing of the repurchases and the number of shares repurchased under the program will depend on a variety of factors including price, trading volume, corporate and regulatory requirements, and market conditions. The Board further authorized Management to enter into a 10b5-1 Plan with a nationally recognized broker-dealer to facilitate share repurchases as appropriate.

Archer Aviation (NYSE: ACHR) today revealed plans for three air taxi networks serving Austin, Dallas–Fort Worth and Houston with the goal of increasing connectivity between major airports, business districts, and coastal destinations in the fastest growing megaregion in the United States.

Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, today announced updated data from the Phase 1b/2 study of JK06, a 5T4-targeted antibody drug conjugate (ADC), in patients with unresectable locally advanced or metastatic solid tumors, including non-small cell lung cancer (NSCLC) and breast cancer. The data are being presented at the European Society for Medical Oncology (ESMO) Congress 2026, taking place October 23-27, 2026, in Madrid, Spain.

Oklo Inc. (NYSE: OKLO) ("Oklo," or "the Company"), an advanced nuclear technology company, today announced it will release its financial results and provide business updates for the third quarter ended September 30, 2026, before market opens on Friday, November 6, 2026, followed by a conference call at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time).

Republic Bancorp, Inc. (“Republic” or the “Company”) reported third quarter 2026 net income and Diluted Earnings per Class A Common Share (“Diluted EPS”) of $31.1 million and $1.59, representing increases of 4% and 5% from the $29.7 million and $1.52 reported for the third quarter of 2025. As a result, the Company achieved a return on average assets (“ROA”) and a return on average equity (“ROE”) of 1.74% and 10.48% for the third quarter of 2026.

Bankjoy, a leading provider of digital banking solutions for community financial institutions, today announced that TEN Credit Union (TENCU), a Nashville-based credit union founded in 1950, has selected Bankjoy as its digital banking platform. TENCU will launch Bankjoy the same day it converts to Corelation's KeyStone core, so members will move to a new core and a new digital banking experience in one coordinated conversion.

Energea, a U.S.-based investment platform that manages energy infrastructure portfolios, today announced that it is expanding its U.S. portfolio beyond solar investments to include electric vehicle (EV) charging investments. Energea Portfolio 4 USA LP (“the Portfolio”) has committed up to $20 million to finance the buildout of EV charging stations.

Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), a leading security technology company pioneering AI-powered solutions designed to create safer experiences, today announced that Evolv Express®, the company’s people-screening platform, and Evolv eXpedite™, the company’s bag-screening platform, has deployed at the Delta Center, the multi-purpose arena in downtown Salt Lake City, UT.

Marcus & Millichap, Inc. (NYSE: MMI), a leading national brokerage firm specializing in commercial real estate investment sales, financing and research and advisory services, announced today it will report its financial results for the third quarter ended September 30, 2026, on Friday, November 6, 2026, before the market open.

K2 Insurance Services announced today that its subsidiary, Aegis General Insurance Agency, will wind down its Executive Risks Division. The division will stop writing new and renewal business effective November 1, 2026. The decision follows a strategic review of the division’s fit within K2’s broader portfolio.

Civeo Corporation (NYSE:CVEO) announced today that it has scheduled its third quarter 2026 earnings conference call for Friday, October 30th, at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). During the call, Civeo will discuss financial and operating results for the third quarter 2026, which will be released after the market closes on Thursday, October 29, 2026.

EagleRock Land, LLC (“EagleRock” or the “Company”), a leading land management royalty company that controls surface acreage in the core of the Permian Basin providing access to land, resources, and infrastructure for critical industries, today announced that it will report 2026 third quarter results after market close on Tuesday, November 3, 2026.

World Acceptance Corporation (NASDAQ: WRLD) today reported financial results for its second quarter of fiscal 2027.

Takeda (TSE:4502/NYSE:TAK) announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS).

SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb (NYSE: BMY) today announced that SystImmune’s parent company Sichuan Biokin Pharmaceutical, Ltd. (Biokin) reported positive results from a prespecified interim analysis of the randomized Phase 3 PANKU-Breast01 study (NCT06343948) evaluating izalontamab brengitecan (iza-bren), an investigational, potentially first-in-class, dual-targeting EGFRxHER3 bispecific antibody-drug conjugate (ADC), versus chemotherapy in patients with unresectable locally advanced, recurrent or metastatic hormone receptor-positive (HR+)/HER2-negative (HER2-) breast cancer who have failed at least one prior line of chemotherapy. Results will be presented today in a late-breaking oral presentation at the European Society for Medical Oncology (ESMO) 2026 Annual Congress taking place October 23–27 in Madrid, Spain, and simultaneously published in The Lancet.

Precisio Biotix Therapeutics, Inc. (“Precisio”), today announced new funding from Gates Foundation to advance a potential new treatment for bacterial vaginosis (BV), one of the most common vaginal conditions affecting women worldwide.

Rithm Capital Corp. (NYSE: RITM; “Rithm Capital,” “Rithm” or the “Company”) today reported the following information for the third quarter ended September 30, 2026.

The Wella Company, the world’s largest pure-play hair and nail company, today announced strategic leadership changes to support its next phase, including a new organizational design for its Global Brand and Marketing function.

Venu Holding Corporation (“VENU” or the “Company”) (NYSE AMERICAN: VENU), an owner, operator, and developer of premium live entertainment destinations, today celebrated the success of Celebrating Land & Sea, A Friends of James Beard Benefit®, hosted October 9 and 10 at the Company’s Roth’s Sea & Steak in Colorado Springs.

American Express Company (NYSE: AXP) today reported its third-quarter 2026 financial results. The earnings release and supplemental financial data are available on the company’s Investor Relations website at http://ir.americanexpress.com.

Star Therapeutics, a biotechnology company focused on the discovery and development of life-changing therapies for diseases with significant unmet need, today announced a $200 million private financing. The financing follows the July 2026 acquisition of Star subsidiary Vega Therapeutics and was co-led by OrbiMed and Janus Henderson Investors, with participation from Agent Capital, Catalio Capital Management, Cormorant Asset Management, New Leaf Venture Partners, NYBC Ventures, RA Capital Management, Redmile, Sofinnova Investments, Soleus Capital, and a leading sovereign wealth fund. Proceeds from the private financing will support Star’s next-generation pipeline of potential best-in-disease therapies, advancing its current preclinical programs into the clinic and expanding its pipeline with additional programs.

ACCO Brands Corporation (NYSE: ACCO) today announced that its board of directors has declared a quarterly cash dividend of $0.075 per share. The dividend will be paid on December 9, 2026, to stockholders of record as of the close of business on November 20, 2026.

Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced that its molecular residual disease (MRD) assay, FoundationOne®MRD,1 has been selected as a winner in The Scientist’s 2026 Top Innovations Contest. Recognized specifically within the Healthcare and Diagnostics category, the honor highlights the most transformative and useful advances in life science techniques and products.

SLB (NYSE: SLB) today announced results for the third-quarter 2026.

Booz Allen Hamilton Holding Corporation (NYSE: BAH), the parent company of advanced technology company Booz Allen Hamilton Inc., today announced preliminary results for the second quarter fiscal 2027.

Avery Dennison Corporation (NYSE:AVY), a leading global materials science and digital identification solutions company, today announced that its Board of Directors has declared a quarterly cash dividend of $1.00 per share. The dividend is payable on December 16, 2026 to shareholders of record on December 2, 2026.

Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.38 per share, payable November 30, 2026, to shareholders of record at the close of business on November 16, 2026.

GrafTech International Ltd. (NYSE: EAF) today announced its unaudited financial results for the quarter and nine months ended September 30, 2026.

The Board of Directors of The Gorman-Rupp Company (NYSE: GRC) has declared a quarterly cash dividend of $0.20 per share on the common stock of the Company, payable December 10, 2026, to shareholders of record November 13, 2026. The cash dividend will represent a 5.3% increase over the $0.19 dividend per share paid in the previous quarter.

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today shared the first data from a global Phase 1b clinical trial evaluating zocilurtatug pelitecan (zoci, formerly ZL-1310) in combination with atezolizumab with and without carboplatin as first-line treatment for extensive-stage small cell lung cancer (ES-SCLC). The data will be presented at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain.

MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading platform for fixed-income securities, today announced financial results for the third quarter ended September 30, 2026.

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Prestonsburg in Kentucky, the Company’s 83rd dispensary nationwide.

The Gorman-Rupp Company (NYSE: GRC) reports financial results for the third quarter ended September 30, 2026.

Dollar Tree (NASDAQ: DLTR) is marking 40 years of bringing incredible value to customers with two milestones that celebrate its roots and invest in its future: the opening of its 9,500th store in Suffolk, Virginia, and a $40 million investment through the newly established Dollar Tree Impact Fund to expand access to everyday essentials and support the well-being of the communities where Dollar Tree operates across the U.S. and Canada.

Today, the Massachusetts Health Connector kicked off the start of Open Enrollment for 2027 health insurance coverage, reminding residents across the Commonwealth to explore their coverage options, compare plans, and get covered. Through January 23, 2027, Massachusetts residents can enroll in new health insurance coverage or review and update their existing health plans and if needed, can access free assistance to help them make informed decisions about their health insurance.

M42, a global health leader powered by artificial intelligence (AI), technology and genomics, and San Diego-based bioinformatics-led company Inocras, have announced a strategic collaboration to advance blood-based monitoring for cancer recurrence in the UAE. Through this partnership, the organizations will deploy Inocras’ MRDVision™ platform—a whole-genome technology suite combining comprehensive genomic profiling with personalized blood assays to detect molecular residual disease (MRD) via circulating tumor DNA (ctDNA), identifying traces of cancer that may remain after treatment and can lead to recurrence.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported positive initial Phase 1b clinical trial results for ALN-HTT02, an investigational RNAi therapeutic in development for the treatment of Huntington’s disease, which will be developed under the International Nonproprietary Name (INN) brezosiran (bre-ZOH-sir-an). The data were presented in oral and poster presentations at the European Huntington’s Disease Network (EHDN) Clinical Research Congress 2026 in Krakow, Poland.

Telefónica and IQM Quantum Computers, a global leader in superconducting quantum computing, have joined forces to deploy the first quantum computer in the Community of Madrid. The initiative will strengthen the region’s scientific and technological capabilities, while driving the development of real-world cases for companies across the Community of Madrid.

Genialis, the therapeutic intelligence company, will present data at the European Society for Medical Oncology (ESMO) Congress 2026 showing that its biology-first models predict treatment response even with limited available patient data. Across three distinct cancer types and treatment regimens, the models demonstrated superior predictive performance in cohorts of fewer than 70 patients, addressing one of the fundamental challenges in developing predictive biomarkers for precision oncology.

AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced updated results from the TheraPb Phase 1 clinical trial (NCT05720130), evaluating ADVC001, an investigational Lead-212 PSMA-targeted alpha therapy, in patients with mAPMR prostate cancer (formerly referred to as mCRPC). The findings were presented at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain.

As announced in the press release, “Nidec Discloses the Investigation Report Issued by the Executive Responsibility Investigation Committee,” dated October 20, 2026, Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) hereby discloses an English version of the digest of the Executive Responsibility Investigation Committee’s investigation report as shown in the attachment, as the translation was completed today.

Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the company’s Injectable Aesthetics portfolio in China – one of the world's largest and fastest-growing aesthetics markets.8,9 This approval follows successful authorizations and launches of Relfydess in more than 35 markets worldwide.

GumGum, the Mindset Company™ transforming advertising, today announced the release of The Marketers' Take On Mindset: 2026 Global Report, revealing that marketers increasingly see consumers’ mindsets as a critical factor in determining advertising relevance, even as many continue to rely on traditional identity-based audience targeting. The report, which surveyed over 2,000 marketers across the US, UK, and Australia, found that while the industry has largely embraced mindset as a principle, adoption as a methodology has yet to catch up.

Members of AM Best’s analytic team will deliver outlook presentations on China’s non-life insurance segment and the global and Asian reinsurance markets at the 2026 Shanghai International Reinsurance Conference, which will take place 27-30 October 2026 in Shanghai, China.

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) an innovation-driven, global biopharma company, today announced that it has entered into a securities purchase agreement for the sale of 11,340,000 American Depositary Shares (“ADSs”), each representing ten ordinary shares of the Company, to certain investors in a private investment in public equity (“PIPE”) financing. The purchase price of each ADS is $22.04. Gross proceeds from the PIPE financing are expected to be approximately $250 million, before deducting placement agent fees and other offering expenses. The PIPE financing is expected to close on or about October 27, 2026, subject to customary closing conditions.

Sensata Technologies (NYSE: ST) today announced that its Board of Directors approved a quarterly dividend in the amount of $0.12 per share. The Company will pay this fourth quarter 2026 dividend on November 25, 2026, to shareholders of record as of November 11, 2026.

Puerto Rico Residents Tax-Free Fund V, Inc. (the "Fund"), a Puerto Rico unlisted corporation registered as a non-diversified closed-end management investment company under the Investment Company Act of 1940, as amended, announced today that, in connection with its ongoing review of options to provide better liquidity, value, and operational efficiencies for Fund shareholders, the Fund’s board of directors (the “Board”) is continuing to pursue alternatives to the Fund’s existing closed-end fund structure.

Attorneys at Hagens Berman issue a retraction regarding public statements made Oct. 13, 2026, concerning the firm’s active sexual assault lawsuit against the University of Washington (UW). 

Metropolitan and its member agencies are investing billions of dollars in projects to keep Southern California’s water supply reliable and safe – and Metropolitan is committed to making sure local, small and diverse businesses have a chance to participate in that work. With both goals in mind, the agency last week hosted its largest-ever MetWorks, with over 1,200 people attending the annual business outreach conference.

PJT Partners Inc. (“PJT Partners”) (NYSE:PJT) announced that it expects to release its third quarter and nine months 2026 financial results on Tuesday morning, November 3, 2026. The earnings release will be available through the Investor Relations section of the PJT Partners website at https://www.pjtpartners.com.

KBRA assigns preliminary ratings to ten classes of mortgage pass-through notes from CLIP 2026-NQM2 Trust, a $349.3 million non-prime RMBS transaction issued by Itasca Park LLC as sponsor. The underlying collateral comprises 602 primarily fixed-rate residential mortgages (FRMs). Guaranteed Rate Entities (28.1%) is the largest originator, and all loans are serviced by Select Portfolio Servicing, Inc. The loans are either classified as non-qualified mortgages (Non-QM) (30.0%), exempt (41.4%) from the Ability-to-Repay/Qualified Mortgage (ATR/QM) rule, QM: Safe Harbor (APOR) (27.5%), or QM: Rebuttable Presumption (APOR) (1.1%).

S&K Aerospace, LLC (SKA) today announced a partnership with SalesPatriot to deploy artificial intelligence and workflow automation across its aerospace maintenance, repair, supply and sustainment operations, including the recently awarded U.S. Air Force Parts and Repair Ordering System 7 (PROS 7) contract.

AllClear Aerospace & Defense (AllClear) has signed a new multi-year exclusive agreement with CEF Industries (CEF). Under the agreement, AllClear will continue to exclusively distribute all CEF product lines globally. As a CEF partner for both distribution and repair, AllClear focuses on supporting military aerospace aftermarket requirements across the globe by listening to our customers and stocking high-demand products that ensure operator readiness.

Consertus, Inc., a portfolio company of RTC Partners, today announced its acquisition of Intueor Consulting, Inc., effective September 1, 2026. Based in Irvine, California, Intueor is a well-established strategy, operations, and technology advisory firm with a strong track record of serving transportation and other public-sector organizations.

FirstCash Holdings, Inc. ("FirstCash" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in FirstCash Holdings, Inc. (NASDAQ: FCFS), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about FirstCash Holdings, Inc. on October 22, 2026.

Boom Supersonic today unveiled its first complete supersonic turbine core, unveiled a 2GW turbine superfactory, and announced it is developing the world’s most advanced all-digital foundry, capable of casting the world’s most advanced single crystal turbine blades and vanes. The Superfactory will create up to 500 high paying jobs. The Superfactory is operational now and already making turbine parts; first single crystal components are expected to ship in 2027.

AMC Entertainment Holdings, Inc. (NYSE: AMC) (“AMC” or “the Company”), the largest theatrical exhibition company in the world, announced today that it will report its results for the third quarter ended September 30, 2026, on Wednesday, November 4, 2026.

Rio Tinto will invest $1.9 billion1 to develop the Kangwinan bauxite project on Western Cape York Peninsula in Queensland, underpinning the long-term future of its Weipa Operations and continued supply to its international customers and its Australian alumina refineries.

James Hardie Industries plc (NYSE / ASX : JHX) ("James Hardie" or the "Company"), a leading provider of exterior home and outdoor living solutions, today announced it will release financial results for the second quarter of its 2027 fiscal year after the market closes in the United States on Thursday, November 5th and before the market opens in Australia on Friday, November 6th. Following the release, the company will hold a conference call to discuss results, hosted by Aaron Erter, CEO and Ryan Lada, CFO. The event will be webcast live on the Investor Relations page of James Hardie’s corporate website (www.jameshardie.com) at the respective times for the following time zones:

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced the appointment of Virginie Maes as President of Aptar Pharma, effective January 1, 2027.

Lucky Strike Entertainment (NYSE: LUCK), one of the world’s premier operators of location-based entertainment, will report financial results for the first quarter of fiscal 2027 on Thursday, November 5, 2026, before the U.S. stock market opens. Management will discuss the results via webcast at 9:00 AM ET on the same day.

Chamberlain University, the nation’s largest school of nursing and a Covista institution, cut the ribbon today on its Salt Lake City campus, its first in Utah and 26th nationwide. The campus welcomes its first cohort of Bachelor of Science in Nursing (BSN) students on Oct. 26.

The Federal Home Loan Bank of Dallas (FHLB Dallas) has awarded nearly $60 million in Affordable Housing Program (AHP) grants to 37 affordable housing projects located in Arkansas, Louisiana, Mississippi, New Mexico and Texas.

Entwistle & Cappucci LLP and Susman Godfrey L.L.P. today announced that they filed a class action complaint (“Complaint”) against Skechers U.S.A., Inc. (“Skechers” or the “Company”) and certain of its officers and directors (collectively, the “Skechers Defendants”), as well as 3G Capital Partners L.P., Greenhill & Co., LLC and related defendants (collectively, “Defendants”) on behalf of a class (the “Class”) consisting of all persons or entities that sold shares of Skechers Class A common stock from April 24, 2025 through September 12, 2025, including those who sold shares in the Take-Private acquisition (the “Take-Private Acquisition”) of Skechers by 3G Capital Partners L.P. and its affiliates on September 12, 2025.

Zevia PBC (“Zevia” or the “Company”) (NYSE:ZVIA), the Company that provides naturally delicious, zero sugar better-for-you beverages, today announced that it has entered into a definitive agreement with a fund managed by GP Investments Ltd. (collectively, “GP Investments”) to issue convertible preferred stock in exchange for $20 million of growth equity to fund key strategic priorities to drive meaningful long-term value creation for shareholders.

VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that, according to the latest Domain Name Industry Brief Quarterly Report from DNIB.com, the third quarter of 2026 closed with 411.6 million domain name registrations across all top-level domains (TLDs), an increase of 9.9 million domain name registrations, or 2.5% compared to the second quarter of 2026. Domain name registrations also increased by 33.0 million, or 8.7%, year over year.

AM Best has revised the outlook to stable from negative for the Long-Term Issuer Credit Ratings (Long-Term ICR) and affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term ICRs of “a+” (Excellent) for the members of Ohio Mutual Insurance Group (OMIG) (Bucyrus, OH). The outlook of the FSR is stable. See below for detailed listing of these companies and Credit Ratings (ratings).

N-able, Inc. (NYSE:NABL), a global cybersecurity company delivering business resilience, today announced that it will host a conference call to discuss its financial results for the third quarter of 2026 at 8:30 a.m. ET on November 5, 2026.

Melar Acquisition Corp. I (“Melar”) (Nasdaq: MACI), a special purpose acquisition company, today announced that at its extraordinary general meeting of shareholders (the “Extraordinary General Meeting”) held today, October 22, 2026, Melar’s shareholders have voted to approve the proposed business combination (the “Business Combination”) with Everli Global Inc., a Nevada corporation (together with its successors, “Everli”), as well as all other proposals related to the Business Combination.

Rivian Automotive, Inc. (NASDAQ: RIVN) today announced it has acquired Third Dimension AI, Inc., a pioneer in AI-powered 3D spatial generation. The strategic transaction will accelerate synthetic data generation and full-world simulation for Rivian's driver assistance and self-driving systems.

Oldcastle BuildingEnvelope, Inc. (OBE), North America’s leading vertically integrated manufacturer, fabricator, and distributor of architectural hardware, glass, and glazing systems, today announced the release of Safety & Security in Design, a joint research report published in strategic partnership with The American Institute of Architects (AIA).

IonQ (NYSE: IONQ), the world’s leading quantum platform and foundry, today announced that the company will release its financial results for the quarter ended September 30, 2026, on Thursday, Nov. 5, 2026, after the financial markets close.